Roles of G protein and β-arrestin in dopamine D2 receptor-mediated ERK activation

被引:24
作者
Quan, Wenying [1 ]
Kim, Ju-Heon [1 ]
Albert, Paul R. [2 ]
Choi, Hyunjin [1 ]
Kim, Kyeong-Man [1 ]
机构
[1] Chonnam Natl Univ, Coll Pharm, Dept Pharmacol, Kwangju 500757, South Korea
[2] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON K1H 8M5, Canada
关键词
Dopamine D-2 receptor; ERK; beta-Arrestin; G protein;
D O I
10.1016/j.bbrc.2008.10.044
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ERK activation by dopamine D-2 receptor (D2R) has been extensively characterized in various cell types including brain tissues. However, the involvement of beta-arrestin in the D2R-rnediated ERK activation is not clear yet. Three different strategies were employed in this study to determine the roles of G Protein or beta-arrestin in D2R-mediated ERK activation. The cellular level of beta-arrestins was reduced by RNA interference and pertussis toxin-insensitive Gi proteins were used to identify the G protein involved. Finally point mutations of D2R in which coupling with G protein was abolished but the interaction with beta-arrestin was increased, were employed to determine whether the affinity between D2R and beta-arrestin is a critical factor for beta-arrestin-mediated ERK activation. Our results show that G(i2) protein is involved in D2R-mediated ERK activation but beta-arrestins are either not involved or play minor role. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:705 / 709
页数:5
相关论文
共 50 条
  • [41] Characterization of dopamine D2 receptor coupling to G proteins in postmortem brain of subjects with schizophrenia
    Egusquiza, Iker
    Munarriz-Cuezva, Eva
    Segarra, Rafael
    Gonzalez-Maeso, Javier
    Callado, Luis F.
    Meana, J. Javier
    Diez-Alarcia, Rebeca
    [J]. PHARMACOLOGICAL REPORTS, 2021, 73 (04) : 1136 - 1146
  • [42] Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia via β-arrestin signaling
    Nagaoka, Koki
    Asaoka, Nozomi
    Nagayasu, Kazuki
    Shirakawa, Hisashi
    Kaneko, Shuji
    [J]. FRONTIERS IN NEUROSCIENCE, 2023, 16
  • [43] Characterization of dopamine D2 receptor coupling to G proteins in postmortem brain of subjects with schizophrenia
    Iker Egusquiza
    Eva Munarriz-Cuezva
    Rafael Segarra
    Javier González-Maeso
    Luis F. Callado
    J. Javier Meana
    Rebeca Diez-Alarcia
    [J]. Pharmacological Reports, 2021, 73 : 1136 - 1146
  • [44] Modulation of A2a receptor antagonist on D2 receptor internalization and ERK phosphorylation
    Li Huang
    Dong-dong Wu
    Lei Zhang
    Lin-yin Feng
    [J]. Acta Pharmacologica Sinica, 2013, 34 : 1292 - 1300
  • [45] Biased Dopamine D2 Receptors Exhibit Distinct Intracellular Trafficking Properties and ERK Activation in Different Subcellular Domains
    Wang, Shujie
    Peng, Lulu
    Kim, Kyeong-Man
    [J]. BIOMOLECULES & THERAPEUTICS, 2024, 32 (01) : 56 - 64
  • [46] G protein-coupled receptor kinase 6/-arrestin 2 system in a rat model of dopamine supersensitivity psychosis
    Oda, Yasunori
    Tadokoro, Shigenori
    Takase, Masayuki
    Kanahara, Nobuhisa
    Watanabe, Hiroyuki
    Shirayama, Yukihiko
    Hashimoto, Kenji
    Iyo, Masaomi
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (12) : 1308 - 1313
  • [47] The role of Gα protein signaling in the membrane estrogen receptor-mediated signaling
    Zheng, Shuhui
    Wu, Lin
    Fan, Chao
    Lin, Jingxia
    Zhang, Yaxing
    Simoncini, Tommaso
    Fu, Xiaodong
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2021, 37 (01) : 2 - 9
  • [48] Antigen receptor-mediated activation of extracellular related kinase (ERK) in B lymphocytes of teleost fishes
    MacDougal, KC
    Mericko, PA
    Burnett, KG
    [J]. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 1999, 23 (03) : 221 - 230
  • [49] Receptor-mediated and receptor-independent activation of G-proteins in rat brain membranes
    Odagaki, Y
    Nishi, N
    Koyama, T
    [J]. LIFE SCIENCES, 1998, 62 (17-18) : 1537 - 1541
  • [50] Disruption of Gi/o protein signaling in the nucleus accumbens results in a D1 dopamine receptor-mediated hyperactivity
    Schroeder, JA
    Hummel, M
    Unterwald, EM
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 79 (01) : 93 - 99